Stock listing

NASDAQ:TBIO Translate Bio Inc Stock

Follow Translate Bio Inc into a list and get an email when it puts out news.

Last close · NASDAQ:TBIO

$37.36 USD

Close on Sep 14, 2021 · No longer trades

Jun 28, 2018 to last close +224.3% · weekly closes, Jun 28, 2018 – Sep 14, 2021
Lowest – highest close
$4.90 – $37.85 USDSince Jun 28, 2018 · lowest Jan 22, 2019 · highest Aug 4, 2021

Delisted NASDAQ:TBIO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:TBIO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Translate Bio Inc on 6ix

Decks
2 decks · latest Aug 25, 2020

Events

QuarterResults
Quarter to Sep 30, 2024Nov 11, 2024 · Before open
Quarter to Jun 30, 2024Aug 7, 2024 · After close
Quarter to Mar 31, 2024May 9, 2024 · After close
Quarter to Dec 31, 2023Mar 28, 2024 · After close
Quarter to Sep 30, 2023Nov 13, 2023 · After close
Quarter to Jun 30, 2023Aug 10, 2023 · After close
Quarter to Mar 31, 2023May 11, 2023 · After close
Quarter to Dec 31, 2022Mar 21, 2023 · After close
Quarter to Sep 30, 2022Nov 8, 2022 · After close
Quarter to Jun 30, 2022Aug 9, 2022 · After close
All 16 quarters
QuarterResults
Quarter to Mar 31, 2022May 10, 2022 · After close
Quarter to Dec 31, 2021Mar 22, 2022 · After close
Quarter to Sep 30, 2021Nov 9, 2021 · After close
Quarter to Jun 30, 2021Aug 10, 2021 · After close
Quarter to Mar 31, 2021Jun 21, 2021 · Before open
Quarter to Dec 31, 2020Feb 25, 2021 · After close

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (August 2020)Technical8 slidesAug 25, 2020
Investor Presentation (January 2020)Investor deck25 slidesJan 13, 2020

Open Decks

Cap table

Built by 6ix from Translate Bio Inc’s releases

Common shares
1,775,839
Fully diluted
1,775,839

Fully diluted

LineShares
Common shares1,775,839

Share count over time

CountShares
Nov 22, 20261,775,839

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jean-François Formela
Other companies: Korro Bio, Inc. (Co-Founder & Director · Since at least Nov 3, 2023); ImageneBio, Inc. (Director · Mar 25, 2021 – Jun 7, 2024 · Past); Spero Therapeutics, Inc. (Director · Nov 1, 2017 – Aug 17, 2021 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – Jun 14, 2022 · Past); Egalet Corporation (Director · Feb 5, 2014 – Feb 11, 2014 · Past); Oruka Therapeutics, Inc. (Director · Feb 10, 2012 – Oct 22, 2012 · Past); Horizon Pharma PLC (Director · Jul 28, 2011 – Mar 2, 2012 · Past)
Director · Jun 27, 2018 – Sep 14, 2021 · Past
Owen Hughes
Other companies: AnaptysBio, Inc. (Member of the Audit Committee · Since at least May 11, 2026); XOMA Royalty Corporation (Chief Executive Officer, Director · Since at least Nov 11, 2024); C4 Therapeutics, Inc. (Director · Since at least Nov 16, 2023); ImageneBio, Inc. (Director · Dec 14, 2022 – Jun 7, 2024 · Past); Pardes Biosciences Inc (Director · Feb 16, 2021 – Dec 23, 2021 · Past); Cullinan Therapeutics, Inc. (President and CEO, Director · Jan 7, 2021 – Jan 12, 2021 · Past); Radius Health, Inc. (Director · Apr 23, 2013 – Aug 15, 2022 · Past)
Director · Jun 27, 2018 – Sep 14, 2021 · Past
Daniella Beckman
Other companies: Upstream Bio, Inc. (Member, Board of Directors · Since at least Oct 10, 2024); Blueprint Medicines Corp (Director · Since at least Dec 8, 2021); Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Aug 10, 2021); Vor Biopharma Inc. (Chair of the Audit Committee · Since at least Feb 4, 2021); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past)
Director · Jun 18, 2019 – Sep 14, 2021 · Past
Everett Rand Sutherland
Other companies: Upstream Bio, Inc. (Chief Executive Officer, Director · Since at least Oct 10, 2024); Krystal Biotech, Inc. (Director · Since at least Jan 18, 2022); Allakos Inc (Director · Jul 31, 2023 – Aug 1, 2023 · Past)
President · Mar 22, 2021 – Sep 14, 2021 · Past
Brian M Gallagher Jr
Other companies: eFFECTOR Therapeutics Inc (Director · Aug 25, 2021 – Jun 13, 2024 · Past); Rein Therapeutics, Inc. (Director · Jun 28, 2017 – Jul 25, 2017 · Past)
Director · Jun 27, 2018 – Jul 2, 2018 · Past
Paul Burgess
Other companies: Kailera Therapeutics, Inc. (Chief Operating Officer & Chief Business Officer · Since at least Apr 16, 2026); Cerevel Therapeutics Holdings Inc (See Remarks · Jun 20, 2023 – Aug 1, 2024 · Past)
General Counsel and Secretary · Jun 27, 2018 – Jun 27, 2018 · Past
Robert Plenge
Other companies: BioMarin Pharmaceutical Inc. (Director · Since at least Sep 10, 2026); Bristol-Myers Squibb Company (EVP, Chief Research Officer · Since at least Jul 3, 2023)
Director · Jun 16, 2021 – Sep 14, 2021 · Past
Ann Barbier
Other companies: Palvella Therapeutics, Inc. (Director · Apr 24, 2018 – Jun 21, 2023 · Past)
Chief Medical Officer · Jun 27, 2018 – Mar 9, 2021 · Past
Brendan Smith
Other companies: CRISPR Therapeutics AG (Chief Financial Officer · Oct 14, 2021 – Feb 18, 2023 · Past)
Chief Financial Officer · Apr 19, 2021 – Sep 14, 2021 · Past
Brian FentonChief Business Officer · Jun 27, 2018 – Mar 8, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Translate Bio Inc.